We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




President Obama Pushes BRAIN Initiative Forward

By LabMedica International staff writers
Posted on 09 Apr 2013
Print article
In his State of the Union address, US President Obama outlined his strategy for creating jobs and building a growing, flourishing middle class by making an historic investment in medical research and development.

“If we want to make the best products, we also have to invest in the best ideas... Every dollar we invested to map the human genome returned USD 140 to our economy... Today, our scientists are mapping the human brain to unlock the answers to Alzheimer’s… Now is not the time to gut these job-creating investments in science and innovation. Now is the time to reach a level of research and development not seen since the height of the space race,” stated President Barack Obama, in the 2013 State of the Union address.

On April 2, 2012, at the White House, the President revealed an intrepid new research initiative designed to transform understanding of the human brain. Initiated with about USD 100 million in the President’s Fiscal Year 2014 Budget, the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative’s goal to help researchers find new ways to treat, cure, and even prevent brain disorders, such as epilepsy, Alzheimer’s disease, and traumatic brain injury.

The BRAIN Initiative is designed to hasten the development and application of new technologies that will enable researchers to produce dynamic pictures of the brain that show how individual brain cells and complex neural circuits interact at the speed of thought. These technologies will create new ways to examine how the brain records, processes, uses, stores, retrieves vast quantities of information, and provide insights into the complex ties between behavior and brain function.

This initiative is one of the Administration’s “Grand Challenges” goals that require new developments in science and technology. In his address, the President called on research universities, companies, research foundations, and philanthropists to join with him in identifying and pursuing the Grand Challenges of the 21st century.

The BRAIN Initiative includes: major investments to jumpstart the effort: The US National Institutes of Health (NIH; Bethesda, MD, USA), the Defense Advanced Research Projects Agency (DARPA; Arlington, VA, USA) , and the US National Science Foundation (Arlington, VA, USA) will support approximately USD 100 million in research beginning in FY 2014. Strong academic leadership: The NIH will establish a high-level working group cochaired by Dr. Cornelia Bargmann (The Rockefeller University; New York, NY, USA) and Dr. William Newsome (Stanford University; Stanford, CA, USA) to clarify detailed scientific goals for the NIH’s investment, and to develop a multiyear scientific plan for achieving these goals, including timetables, milestones, and cost estimates.

In the 10 years alone, scientists have made a number of landmark discoveries that now create the opportunity to gain further knowledge of the brain, including the sequencing of the human genome, the increasing resolution of imaging technologies, the development of new tools for mapping neuronal connections, and the expansion of nanoscience. These innovations have offered a chance for unprecedented collaboration and discovery across scientific fields. For instance, by combining sophisticated genetic and optical technologies, scientists can now use pulses of light to determine how specific cell activities in the brain affect behavior. Moreover, through the integration of neuroscience and physics, researchers can now use high-resolution imaging technologies to observe how the brain is structurally and functionally connected in living humans.

Whereas these technologic contributions have substantially added to expanding knowledge of the brain, significant breakthroughs in how physicians treat neurologic and psychiatric disease will require a new generation of applications to enable researchers to map signals from brain cells in much greater numbers and at even faster speeds. This cannot presently be accomplished, but great potential for developing such technologies lies at the crossroads of imaging, nanoscience, engineering, informatics, and other rapidly budding fields of science and engineering.

Related Links:

US National Institutes of Health
US Defense Advanced Research Projects Agency
US National Science Foundation


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.